157 related articles for article (PubMed ID: 28906590)
1. FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.
Zhang X; Kong M; Zhang Z; Xu S; Yan F; Wei L; Zhou J
Thorac Cancer; 2017 Nov; 8(6):655-665. PubMed ID: 28906590
[TBL] [Abstract][Full Text] [Related]
2. Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients.
Tan Q; Li F; Wang G; Xia W; Li Z; Niu X; Ji W; Yuan H; Xu Q; Luo Q; Zhang J; Lu S
Oncotarget; 2016 Apr; 7(14):18394-402. PubMed ID: 26943773
[TBL] [Abstract][Full Text] [Related]
3. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.
Zhang S; Liang X; Zheng X; Huang H; Chen X; Wu K; Wang B; Ma S
Int J Clin Exp Pathol; 2014; 7(5):2079-90. PubMed ID: 24966916
[TBL] [Abstract][Full Text] [Related]
4. FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma.
Gao L; Lang L; Zhao X; Shay C; Shull AY; Teng Y
Oncogene; 2019 Mar; 38(13):2394-2404. PubMed ID: 30518874
[TBL] [Abstract][Full Text] [Related]
5. IncRNA PLAC2 Upregulates CDK6 by Directly Targeting miR-29C to Promote Cell Proliferation in Lung Squamous Cell Carcinoma.
Zhao X; He X; Wang M; Zhang H; Cheng J; Wang H
Crit Rev Eukaryot Gene Expr; 2022; 32(8):55-67. PubMed ID: 36017916
[TBL] [Abstract][Full Text] [Related]
6. MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop.
Luo P; Wang Q; Ye Y; Zhang J; Lu D; Cheng L; Zhou H; Xie M; Wang B
J Exp Clin Cancer Res; 2019 Feb; 38(1):74. PubMed ID: 30755230
[TBL] [Abstract][Full Text] [Related]
7. SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.
Xu J; Yang S; Gu X; Shen H; Wang L; Xu W; Fang L; Mao Y; Xu L; Chen Y; Fan W; Wang J
Exp Mol Pathol; 2019 Oct; 110():104276. PubMed ID: 31233732
[TBL] [Abstract][Full Text] [Related]
8. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin.
Torres-Ayuso P; An E; Nyswaner KM; Bensen RC; Ritt DA; Specht SI; Das S; Andresson T; Cachau RE; Liang RJ; Ries AL; Robinson CM; Difilippantonio S; Gouker B; Bassel L; Karim BO; Miller CJ; Turk BE; Morrison DK; Brognard J
Cancer Discov; 2021 Jun; 11(6):1411-1423. PubMed ID: 33495197
[TBL] [Abstract][Full Text] [Related]
9. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer.
Zhu W; Huang M; Thakur A; Yan Y; Wu X
PeerJ; 2023; 11():e14827. PubMed ID: 36751636
[TBL] [Abstract][Full Text] [Related]
10. Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.
Xiang C; Lv Y; Wei Y; Wei J; Miao S; Mao X; Gu X; Song K; Jia S
Cell Physiol Biochem; 2015; 36(2):435-45. PubMed ID: 25968442
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.
Yang F; Ma H; Feng L; Lian M; Wang R; Fan E; Fang J
Int J Clin Exp Pathol; 2015; 8(11):13886-99. PubMed ID: 26823701
[TBL] [Abstract][Full Text] [Related]
12. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Ming F; Sun Q
Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
[TBL] [Abstract][Full Text] [Related]
13. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
15. HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosis.
Song X; Liao Z; Zhou C; Lin R; Lu J; Cai L; Tan X; Zeng W; Lu X; Zheng W; Chen J; Su Z
Oncol Rep; 2017 Oct; 38(4):2444-2452. PubMed ID: 28849239
[TBL] [Abstract][Full Text] [Related]
16. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
Yuan H; Jiang H; Wang Y; Dong Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
Miura S; Mitsuhashi N; Shimizu H; Kimura F; Yoshidome H; Otsuka M; Kato A; Shida T; Okamura D; Miyazaki M
BMC Cancer; 2012 Feb; 12():56. PubMed ID: 22309595
[TBL] [Abstract][Full Text] [Related]
19. CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis.
Tian L; Cao J; Jiao H; Zhang J; Ren X; Liu X; Liu M; Sun Y
Clin Sci (Lond); 2019 May; 133(9):1053-1066. PubMed ID: 30992382
[No Abstract] [Full Text] [Related]
20. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.
Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S
Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
